MarketPeel
Insider Trading Intelligence
Pricing
…
RG

Robert E. Gagnon

IRD
CHIEF FINANCIAL OFFICER · OPUS GENETICS, INC. · CIK 0001504983
FILING MIX · LIFETIME41%/59%
BUYS
22
SELLS
32
TOTAL VALUE
$509.1K
COMPANIES
4
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
724,286
AVG SELL PX
$3.62
TRADE KIND
SHOWING 54 / 54
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
31 backtested trades · 8 horizons · 14 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robert E. Gagnon, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d31+67.74%-5.44%+0.11%-5.55%-7.09%-3.63
14d31+58.06%-3.75%+0.50%-4.25%-6.34%-1.48
30d31+50.00%-0.29%+0.65%-0.94%-1.05%-0.20
60d31+51.61%+1.49%+2.65%-1.16%-6.19%-0.20
90d31(1 pending)+46.67%+5.94%+3.50%+2.44%-1.42%0.32
180d31(1 pending)+53.33%+2.47%+6.57%-4.10%-15.74%-0.32
1y31(3 pending)+64.29%+4.62%+16.81%-12.19%-48.29%—
2y31(9 pending)+63.64%-22.82%+39.63%-62.45%-62.95%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IRD · 592,158 shares · as of Apr 23, 2026
0150,000300,000450,000600,0002026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 22 buys / 32 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HBIO
HARVARD BIOSCIENCE INC
PURCHASEGRANT
Stock grant
16,556——27,556Jun 9, 2026Jun 11, 2026 ↗View →
IRD
OPUS GENETICS, INC.
SALE
Chief Financial Officer
7,842$5.18$40.7K592,158Apr 23, 2026Apr 27, 2026 ↗View →
IRD
OPUS GENETICS, INC.
PURCHASEGRANT
Stock grant
400,000——600,000Jan 22, 2026Jan 26, 2026 ↗View →
VSTM
VERASTEM, INC.
SALE10b5-1
10b5-1 plan
283$9.14$2.6K41,678Dec 16, 2025Dec 18, 2025 ↗View →
VSTM
VERASTEM, INC.
SALE10b5-1
10b5-1 plan
281$9.99$2.8K41,961Sep 16, 2025Sep 18, 2025 ↗View →
IRD
OPUS GENETICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Sep 10, 2025Sep 11, 2025 ↗View →
IRD
OPUS GENETICS, INC.
PURCHASEGRANT
Stock grant
250,000——250,000Sep 2, 2025Sep 11, 2025 ↗View →
HBIO
HARVARD BIOSCIENCE INC
PURCHASEGRANT
Stock grant
110,000——110,000Jul 16, 2025Jul 18, 2025 ↗View →
VSTM
VERASTEM, INC.
SALE
284$5.65$1.6K42,242Jun 16, 2025Jun 20, 2025 ↗View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
62,894——62,894Jun 4, 2025Jun 6, 2025 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
8,333——42,526May 22, 2025May 27, 2025 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
12,500——12,500May 22, 2025May 27, 2025 ↗View →
VSTM
VERASTEM, INC.
SALE
284$6.95$2.0K34,193Mar 17, 2025Mar 19, 2025 ↗View →
VSTM
VERASTEM, INC.
SALE
130$4.37$56834,477Dec 19, 2024Dec 20, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
285$4.54$1.3K34,607Dec 16, 2024Dec 20, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
131$2.79$36534,892Sep 19, 2024Sep 20, 2024 ↗View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
30,713——30,713Sep 17, 2024Sep 19, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
287$2.80$80435,023Sep 16, 2024Sep 18, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
131$3.21$42135,310Jun 20, 2024Jun 20, 2024 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
8,333——35,441Jun 18, 2024Jun 20, 2024 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
12,500——12,500Jun 18, 2024Jun 20, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
283$3.49$98827,108Jun 17, 2024Jun 20, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
130$10.38$1.3K27,391Mar 19, 2024Mar 20, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
283$10.71$3.0K27,521Mar 18, 2024Mar 20, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE10b5-1
10b5-1 plan
9,204$13.70$126.1K27,804Feb 6, 2024Feb 7, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE10b5-1
10b5-1 plan
9,204$10.95$100.8K37,008Jan 12, 2024Jan 17, 2024 ↗View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
8.006——8,015Jan 8, 2024Jan 10, 2024 ↗View →
BBLG
BONE BIOLOGICS CORP
PURCHASEGRANT
Stock grant
9——9Jan 8, 2024Jan 10, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
130$7.73$1.0K46,212Dec 19, 2023Dec 20, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
284$7.64$2.2K46,342Dec 18, 2023Dec 20, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
130$9.84$1.3K46,626Sep 19, 2023Sep 20, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
278$9.91$2.8K46,756Sep 18, 2023Sep 20, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
130$10.30$1.3K47,034Jun 20, 2023Jun 21, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
283$9.92$2.8K47,164Jun 16, 2023Jun 21, 2023 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
62,500——62,500May 15, 2023May 16, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
1,664$0.43$716569,399Mar 20, 2023Mar 20, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
3,654$0.40$1.5K571,063Mar 16, 2023Mar 20, 2023 ↗View →
VSTM
VERASTEM, INC.
SALE
1,429$0.37$529574,717Dec 19, 2022Dec 20, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
12,408$0.40$5.0K576,146Dec 16, 2022Dec 20, 2022 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
153,938——153,938Dec 13, 2022Dec 15, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
1,348$1.13$1.5K588,554Sep 19, 2022Sep 21, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
1,351$1.14$1.5K589,902Jun 21, 2022Jun 22, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
16,627$1.03$17.1K591,253May 16, 2022May 17, 2022 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
50,000——607,880May 14, 2022May 17, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
1,409$1.27$1.8K557,880Mar 21, 2022Mar 23, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
19,612$2.05$40.2K559,289Jan 3, 2022Jan 5, 2022 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
5,497$2.27$12.5K578,901Dec 20, 2021Dec 22, 2021 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
148,500——584,398Dec 15, 2021Dec 17, 2021 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
301,500——301,500Dec 15, 2021Dec 17, 2021 ↗View →
VSTM
VERASTEM, INC.
SALE
Chief Financial Officer
45,329$2.87$130.1K435,898Aug 12, 2021Dec 17, 2021 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
203,776——203,776Dec 18, 2020Dec 22, 2020 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
67,925——571,635Dec 18, 2020Dec 22, 2020 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
290,210——503,710Aug 11, 2020Aug 13, 2020 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
62,500——213,500Mar 27, 2020Mar 30, 2020 ↗View →
Other insiders · IRD
Loading peer insiders…
About this filer
CIK 0001504983
ROLE
Chief Financial Officer
PRIMARY
IRD
COMPANIES
4
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001504983DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback